Blazar


Unlocking the potential in Cancer Immunotherapies.


Learn More

Immunotherapies

Using the immune system to fight cancer

Immunotherapies are a groundbreaking cancer treatment curing patients with a success impossible five years ago.

There are some challenges:

Low Response Rate

Only work in 20-30% of patients.

Serious Adverse Effects

Unique spectrum of side effects and fatal toxicities may occur.

Costly

High per-patient price and costly to develop

Our Solution



Prediction of response and resistance to treatment


Insights on non-response and acquired resistance to treatment


Integration of biopsies images and other datasets

Meet The Team

Dora Sabino, Ph.D
Co-founder & CEO

Dora completed her PhD at Cambridge and has 14 years of experience in cancer research.

Renan Pereira
Co-founder & CTO

Renan is a Data Scientist with extensive experience in developing and managing scalable Machine Learning models.




Featured on


                                                                   




Supported by




Entrepreneur First

Get In Touch

Blazar SAS
Station F
5 Parvis Alan Turing, 75013
Paris, France


info@blazar.ai